Zacks Research Forecasts Plexus’ Q2 Earnings (NASDAQ:PLXS)

Plexus Corp. (NASDAQ:PLXSFree Report) – Equities research analysts at Zacks Research reduced their Q2 2025 earnings per share (EPS) estimates for Plexus in a report issued on Wednesday, February 5th. Zacks Research analyst V. Doshi now forecasts that the technology company will earn $1.32 per share for the quarter, down from their previous forecast of $1.37. The consensus estimate for Plexus’ current full-year earnings is $5.94 per share. Zacks Research also issued estimates for Plexus’ Q3 2025 earnings at $1.49 EPS, Q4 2025 earnings at $1.65 EPS, FY2025 earnings at $5.95 EPS, Q1 2026 earnings at $1.61 EPS, Q2 2026 earnings at $1.55 EPS, Q3 2026 earnings at $1.76 EPS, Q4 2026 earnings at $1.90 EPS, FY2026 earnings at $6.81 EPS, Q1 2027 earnings at $1.82 EPS and FY2027 earnings at $7.70 EPS.

Several other equities research analysts have also weighed in on PLXS. KeyCorp began coverage on Plexus in a research report on Tuesday, October 22nd. They issued a “sector weight” rating on the stock. Stifel Nicolaus initiated coverage on Plexus in a research note on Tuesday, February 4th. They set a “hold” rating and a $152.00 price target for the company. Benchmark reiterated a “buy” rating and issued a $165.00 target price on shares of Plexus in a report on Wednesday, January 22nd. Needham & Company LLC increased their price target on Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Finally, StockNews.com raised shares of Plexus from a “hold” rating to a “buy” rating in a research note on Monday, November 18th. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Plexus currently has a consensus rating of “Moderate Buy” and a consensus target price of $163.00.

View Our Latest Stock Report on Plexus

Plexus Stock Up 0.4 %

NASDAQ:PLXS opened at $141.76 on Monday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.70 and a current ratio of 1.53. Plexus has a one year low of $90.18 and a one year high of $172.89. The stock has a 50-day simple moving average of $158.06 and a 200 day simple moving average of $144.17. The company has a market capitalization of $3.83 billion, a price-to-earnings ratio of 32.89 and a beta of 0.89.

Plexus (NASDAQ:PLXSGet Free Report) last posted its earnings results on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing analysts’ consensus estimates of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%.

Hedge Funds Weigh In On Plexus

A number of large investors have recently added to or reduced their stakes in the company. Handelsbanken Fonder AB grew its stake in Plexus by 10.6% in the third quarter. Handelsbanken Fonder AB now owns 6,237 shares of the technology company’s stock valued at $853,000 after purchasing an additional 600 shares in the last quarter. GAMMA Investing LLC raised its stake in Plexus by 190.1% in the third quarter. GAMMA Investing LLC now owns 760 shares of the technology company’s stock valued at $104,000 after purchasing an additional 498 shares in the last quarter. Creative Planning boosted its holdings in shares of Plexus by 56.0% in the 3rd quarter. Creative Planning now owns 14,616 shares of the technology company’s stock valued at $1,998,000 after purchasing an additional 5,245 shares in the last quarter. nVerses Capital LLC bought a new stake in shares of Plexus during the 3rd quarter valued at approximately $178,000. Finally, Trust Point Inc. bought a new position in Plexus in the third quarter valued at about $208,000. Institutional investors own 94.45% of the company’s stock.

Insider Activity

In related news, CEO Todd P. Kelsey sold 4,337 shares of Plexus stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $142.23, for a total value of $616,851.51. Following the completion of the transaction, the chief executive officer now directly owns 80,595 shares of the company’s stock, valued at $11,463,026.85. The trade was a 5.11 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Patrick John Jermain sold 3,361 shares of the stock in a transaction on Monday, January 27th. The shares were sold at an average price of $144.57, for a total value of $485,899.77. Following the completion of the transaction, the chief financial officer now owns 20,745 shares in the company, valued at $2,999,104.65. The trade was a 13.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,239 shares of company stock worth $2,212,730. Company insiders own 1.76% of the company’s stock.

Plexus Company Profile

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Featured Articles

Earnings History and Estimates for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.